Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics IV: Molecular Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Farouc Jaffer

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Habib Samady

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics II: NIRS-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, David Erlinge

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics I: OCT-Derived Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches II: NaF PET

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Bon-Kwon Koo

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches I: CT-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, James K. Min

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Presenter: John A. Ambrose, Y. S. Chandrashekhar, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James A. Goldstein

November 01, 2017

Podcast TCTMD Talking Points

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

October 18, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Caitlin E. Cox

May 15, 2017

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

Advertisement

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Novel Invasive Diagnostics IV: Molecular Imaging

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

Novel Invasive Diagnostics II: NIRS-Based

Novel Invasive Diagnostics I: OCT-Derived Imaging

Novel Noninvasive Approaches II: NaF PET

Novel Noninvasive Approaches I: CT-Based

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content